| Literature DB >> 32299652 |
Ghislain Opdenakker1, Ahmed Abu El-Asrar2, Jo Van Damme3.
Abstract
Autoimmune diseases are defined as pathologies of adaptive immunity by the presence of autoantibodies or MHC-restricted autoantigen-reactive T cells. Because autoreactivity is a normal process based on mechanisms producing repertoires of antibodies and T cell receptors, crucial questions about disease mechanisms and key steps for interference have been outstanding. We defined 25 years ago the 'remnant epitopes generate autoimmunity' (REGA)-model in which extracellular proteases from innate immune cells generate autoantigens. Here, we refine the REGA-model, tested in diseases ranging from organ-specific autoimmune diseases to systemic lupus erythematosus. It now constitutes a paradigm in which remnant epitopes generate, maintain, and regulate autoimmunity; are dependent on genetic and epigenetic influences; are produced in a disease phase-specific manner; and have therapeutic implications when targeted.Entities:
Keywords: Autoimmunity; Chemokines; Citrullination; Cytokines; Glycation; Post-translational modification; Proteases
Year: 2020 PMID: 32299652 DOI: 10.1016/j.it.2020.03.004
Source DB: PubMed Journal: Trends Immunol ISSN: 1471-4906 Impact factor: 16.687